K.RahmanS.CuculloL
These side effects are more likely to occur in people who have a history of these conditions or risk factors for these conditions
Indias anti-obesity pharmaceutical market surged to Rs 628 crore as per the moving annual total (MAT) ending June 2025, a five-fold increase over five years with a 46 percent CAGR, making it the fastest-growing therapeutic segment in the Indian pharma landscape, according to market research firm PharmaTrac
At TrimRx, our brand personality is deeply rooted in being empathetic, innovative, trustworthy, supportive, results-oriented, and personalized
Nausea (40%), flushing (20%), headache (11%), injection-site reaction (13%)
GLP-1 medications bind to GLP-1 receptors in the brain, particularly in areas controlling appetite and satiety, which leads to reduced hunger and increased feelings of fullness after eating